Jason Stadanlick Ph.D.

Jason Stadanlick Ph.D. has a wide range of work experience. Jason began their career in 1997 as a Laboratory Technician at the Laboratory of Alan Mast, where they were responsible for protein purification and analysis, as well as procuring and managing laboratory supplies. In 2000, they became a Graduate Student, Teaching Assistant, and Laboratory Manager at the University of Pennsylvania, where they completed their thesis work in the laboratory of Dr. Mike Cancro. In 2008, they became a Post Doctoral Associate at Fox Chase Cancer Center. From 2010 to 2013, they were a Lecturer at Arcadia University. In 2013, they became a Research Scientist at Vitae Pharmaceuticals. From 2016 to 2019, they were a Senior Research Scientist at the University of Pennsylvania, where they studied how intra-tumoral neutrophils and macrophages modulate the anti-tumor immune response in early stage human non-small cell lung cancer. In 2019, they became a Research Scientist at Spark Therapeutics, Inc., where they conducted assays to predict immune responses to gene therapy vectors and trans genes. Finally, in 2021, they became an Associate Principal Scientist and Senior Scientist at Cabaletta Bio.

Jason Stadanlick Ph.D. began their educational journey in 1990 at Council Rock High School. Jason then attended Penn State University from 1992 to 1996, where they earned a Bachelor of Science in Biology. In 2003, they enrolled at the University of Pennsylvania School of Medicine and completed their Ph.D. in Immunobiology in 2008.